News & Research Feed

Semaglutide News & Research

Semaglutide clinical evidence, real-world outcomes, and regulatory developments.

All Retatrutide Tirzepatide Semaglutide Peptide Therapy FDA Updates Clinical Trials Editorial

PubMed Semaglutide

Unexplained hypercapnia with normal pulmonary evaluation in a patient receiving semaglutide: a diagnostic challenge

Prasad S, Ahuja A, Katwa LC, et al. — JCEM case reports

2026-05-01 Read source →

PubMed Semaglutide

Oral Semaglutide Sustains Long-Term CVD Risk Factor Reductions

Anderer S — JAMA

2026-04-24 Read source →

PubMed Semaglutide

Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: a phase 3, randomized, active-controlled trial (SIZE-DM study)

Kapoor N, Shaikh S, Bhattacharya S, et al. — Cardiovascular diabetology. Endocrinology reports

2026-04-24 Read source →

PubMed Semaglutide

Glucagon-like peptide-1 and atrial fibrillation incidence: Associations independent of weight loss

Palmisano T, Verma R, Guarraia D, et al. — Heart rhythm

2026-04-23 Read source →

PubMed Semaglutide

Efficacy, Safety and PK of Once-Daily Oral Semaglutide 25 mg for Obesity With and Without Type 2 Diabetes in Comparison With Subcutaneous Semaglutide 2.4 mg: A Model-Informed Drug Development Approach

Overgaard RV, Birkhan O, Rathor N, et al. — Diabetes, obesity & metabolism

2026-04-23 Read source →

PubMed Semaglutide

Semaglutide for obesity management: A narrative review of efficacy, safety, and future directions

Hajibandeh S, Tao YA, Hsieh MH, et al. — Journal of the American Pharmacists Association : JAPhA

2026-04-21 Read source →

PubMed Semaglutide

Liver benefits of early initiation of low-dose GLP-1 receptor agonists in newly diagnosed type 2 diabetes - A case report

Lee JY, Nguyen H, Nguyen T — Journal of family medicine and primary care

2026-02-01 Read source →

Sources & methodology. Items aggregated from public scientific and regulatory sources: PubMed (NCBI E-utilities), FDA press releases, and ClinicalTrials.gov v2 API. Summaries are factual excerpts from source records — no editorial commentary. Inclusion does not imply endorsement, and items are not medical advice. Last regenerated: 2026-04-26.